Ambroxol Lozenges 20mg in Relieving the Pain of Sore Throat in Adolescent Patients With Acute Viral Pharyngitis
Status:
Completed
Trial end date:
2005-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this trial is to investigate efficacy and tolerability of lozenges containing
20mg am broxol hydrochloride relative to placebo in relieving pain of sore throat in
adolescent patients suf fering from acute viral pharyngitis. The primary endpoint is the
time-weighted average of the pain intensity difference from pre-dose bas eline over the first
3 hours after the first lozenge expressed as a ratio of the pre-dose baseline ( SPIDnorm).